featured
Hard Science Shows MRNa Vaccines Increase Cancer Risk // Jimmy Dore
Jimmy Dore | Trusted Newsmaker
New Study Raises Concerns Over Cancer Risks After mRNA Vaccination
A peer-reviewed study published in the journal *Experimental and Clinical Sciences* has ignited debate after reporting significant increases in cancer incidence following mRNA vaccination. Conducted in Italy, the research tracked nearly 300,000 people over two and a half years, examining hospitalization data for newly diagnosed cancers .
Study Findings
The analysis revealed that within six months of vaccination, the risk of hospitalization for cancer rose sharply compared to the unvaccinated group. Key findings include:
– All cancers: 23% higher incidence among vaccinated individuals.
– Colorectal cancer: 34% higher risk.
– Breast cancer: 54% higher risk.
– Bladder cancer: 62% higher risk.
– Uterine and ovarian cancers: 75% and 66% higher risk, respectively, though statistical significance varied due to smaller case numbers .
Sample Size and Statistical Significance
Of the nearly 300,000 participants, 3,124 were hospitalized with cancer during the study period. Among the unvaccinated, 0.85% developed cancer, compared to 1.15% of the vaccinated. While this may seem small, the difference translates to thousands of additional cases when applied to larger populations. Researchers noted that certain cancer types did not reach statistical significance, but trends across multiple categories suggest cause for concern .
Possible Biological Mechanisms
Scientists cited several potential mechanisms linking mRNA vaccination to cancer risk:
– Chronic inflammation triggered by spike protein production.
– Autoimmune responses attacking healthy tissues.
– DNA contamination or frame-shifting errors leading to rogue proteins.
– Suppression of tumor-suppressor genes.
These theories remain under investigation, but they align with established cancer biology, where chronic inflammation and genetic mutations are key drivers .
Limitations of the Study
The authors emphasized that these findings are preliminary. Important caveats include:
– Healthy vaccine effect: Those who sought vaccination tended to be healthier overall, which may skew data.
– Short follow-up period: Cancer often develops over years or decades, making long-term studies essential.
– Regional data: Results are based on one province in Italy and may not reflect global populations .
Why This Matters
If these findings hold true across larger cohorts, they could reshape how mRNA technology is evaluated for safety. Governments worldwide promoted these vaccines under emergency authorization, but long-term data on cancer risks were never collected before rollout. Transparency issues also complicate analysis — in the UK, for example, researchers have been denied access to raw vaccination and health outcome data .
The Italian study signals a possible link between mRNA vaccines and higher cancer risk, with colorectal, breast, and bladder cancers showing the most significant increases. While the data is far from definitive, it underscores the urgent need for independent, long-term research. Public health officials face mounting pressure to release raw data and allow broader scrutiny. For now, the scientific community remains divided — but the early warning signs should not be ignored .
//
